Revolution Cannabis Analytics strives to make our platform the most accurate company in cannabis in order to facilitate production of better and more precise cannabinoid medicines.
We formed Revolution Cannabis Analytics to capture data through research to better understand the unique effects of cannabinoids and terpenoids and their combined entourage affect. Using analytical information supplied by Revolution Cannabis Analytics allows us to create the next generation of Revolution genetic varieties to precisely address specific debilitating conditions.
Revolution Cannabis Analytics has put together a group of leading doctors and scientists to study the unique effects of each variety and each chemical component through physiological measurement focusing on such areas as mental function, inflammation, immune function, stimulation and sleep, metabolism (weight loss), and appetite arousal (weight gain).
Medical Cannabis Patient Survey
Revolution Cannabis Analytics recently partnered with four Illinois state-registered dispensaries to administer surveys to voluntary medical cannabis patient participants. The anonymous surveys were available from participating dispensaries for patients to take home and complete on their own time, and were collected through Jan. 8, 2016.
The Medical Cannabis Patient Survey asked patients to rate their experience with each strain they purchase from the dispensary, focusing on symptoms associated with pain, sleep, nausea, and more. The survey also collects basic patient demographics such as age range and zip code.
Illinois created strict controls within its pilot program, including the implementation of third-party testing and labeling requirements. The results of lab testing are printed on all medical cannabis labels, allowing for accurate, groundbreaking research.
In March, Revolution Cannabis Analytics announced the results, which included that more than 90 percent of Illinois medical cannabis patients said they found pain relief with any strain of cannabis. These results are consistent with other states’ findings where doctors can recommend medical cannabis for pain. Indeed, states that allow for this type of treatment have about a 25 percent lower rate of opioid overdose deaths on average.